Date and Place:
March 21 2018
Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried
1:00 pm - 8:00 pm
The event is free of charge but registration is recommended.
Max Planck Alumni Association (MPAA) is organizing a series of events focused on Big data, AI and drug development.
The first workshop with BioM as partner is entitled: Artificial Intelligence and Big Data in Pharma - Impact on drug development and on the role of the industry.
New technologies, such as Big data and Artificial Intelligence (AI), are progressively changing the process of drug and clinical development. Currently these new technologies are being adopted by big pharma players, such as Novartis. Smaller biotech companies can also benefit from applying Big data and AI to their process of drug and clinical development. This workshop aims to provide an overview about Big data and AI to non-experts of this field working in biotech. Selected topics include AI in personalized medicine, drug discovery, pre-clinical and clinical development. Besides presentations on these topics, there will be a panel discussion in which invited experts are sharing their views on the advantages and challenges of implementing Big data and AI on biotech companies working in drug development.
13:00 – 13:15 Opening words
13:20 – 13:50 Overview about AI in Healthcare
Speakers: Justus Wolff and Andreas Keck, Syte Founder
13:55 – 14:25 AI in personalized medicine
Speaker: Pedro B. Faustino, SimplicityBio COO
14:30 – 15:00 Coffee break
15:00 – 15:30 AI in drug discovery
Speaker: Jeremy Besnard, Exscentia CSO
15:35 – 16:05 AI in preclinical, clinical, regulatory and commercial stages of a drug
Speaker: Gunjan Bhardwaj, Innoplexus CEO
16:10 – 17:10 Panel discussion
17:15 – 17: 20 Final words
17:20 – 18:00 Mingling
More information and registration under: http://www.mpg-alumni.de/event/aiworkshop/